review on glp-1 agonists and psychiatric effects The Impact of Receptor (GLP-1 RAs) Mental Health: A Systematic | Current Treatment Options in Psychiatry Frontiers | Exploring the multifaceted

In addition, a recent analysis of the SELECT trial results showed that semaglutide use was associated with a substantial reduction in non-CV death

Weight Loss Effectiveness The clinical data shows a clear effectiveness advantage for semaglutide

Convenient Home Delivery Get your medication delivered directly, if prescribed

Potential eligibility considerations may include: BMI thresholds: Adults with BMI 30 kg/m or 27.5 kg/m for people of South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean family background (adjusted thresholds reflect higher metabolic risk at lower BMI in certain ethnic groups) Previous weight management attempts: Evidence of engagement with dietary modification, increased physical activity, and behavioural interventions through a specialist weight management service Absence of contraindications: Specific contraindications will be defined in the Summary of Product Characteristics (SmPC) if the medicine is authorised Commitment to lifestyle modification: Willingness to participate in a comprehensive weight management programme Clinical trials have typically excluded individuals with recent cardiovascular events, severe renal or hepatic impairment, pregnancy or planned pregnancy, and those with a history of pancreatitis

Partnering with psychologists to help address adherence, barriers and high-risk behaviors is essential

Trial objective and outcomes The objective of this trial was to determine whether a 3-week treatment with the GLP-1 RA dulaglutide compared with placebo reduces fluid intake in patients with primary polydipsia